Poly-omic Predictors of Symptom Duration and Recovery for Adolescent Concussion

NCT04582682 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2026-03-11

No results posted yet for this study

Summary

The purpose of this study is to identify changes in salivary micro ribonucleic acid (miRNA) levels that are predictive of symptom duration and character following mild traumatic brain injury (mTBI) in children.

Conditions

  • Concussion, Mild

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Steve Hicks, MD, PhD · Penn State University, College of Medicine

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-18
Primary Completion
2025-11-01
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04582682 on ClinicalTrials.gov